Annovis Promotes Research Chief as Lead Drug Nears Key Trial
MALVERN, PA — Annovis Bio (NYSE: ANVS) has promoted Cheng Fang to chief scientific officer as the biotechnology company prepares for pivotal clinical and regulatory milestones for its lead drug …
Annovis Promotes Research Chief as Lead Drug Nears Key Trial Read More